Background: Several studies have well-established the relationship between breast cancer and etiological hormonal factors. Therefore, the aim of this study was to determine breast cancer related awareness and approach toward exposure to diverse patterns of hormones among women in Northern Saudi Arabia. Methodology: This is a cross sectional survey included 400 Saudi females’ volunteers living in the city of Hail, Northern Saudi Arabia. Knowledge, awareness and approach toward exposure to diverse patterns of hormones and breast cancer risk were evaluated using different variables during interview. Results: On asking the participants the question “Does the over exposure to hormones (ER) increases the risk of breast cancer” Out of 387 respondents, 47.5% answered yes increases the risk of breast cancer. On asking the participants the question “Does early puberty and late menopause increase the risk of breast cancer” Out of 395 respondents, 35.2% answered yes increases the risk of breast cancer. Conclusion: Knowledge of hormonal breast cancer risk factors is not so strong so as to achieve the intended values in Northern Saudi Arabia. Knowledge of breast cancer risk factors can powerfully participate to the breast cancer prevention struggles, which will have the chief results mainly if started at an early age and continued over a lifetime.
Breast cancer is a prevalent disease affecting all areas of the patients' lives 1. Breast cancer incidence in countries with higher development is greater, while mortality is greatest in countries with less development 2. Epidemiological characteristics of breast cancer seem to be dissimilar in developing countries compared to Western countries, with remarkably large proportions of young patients, male patients and aggressive forms of the disease. Such epidemiological characteristics result mostly from unusual risk factor profiles, which are distinctive for several developing countries and comprise notably fast alterations in reproductive behaviors. These characteristics have important implications for breast cancer control and treatment 3.
The relation between estrogen production and breast cancer development is well-known since 1896 when George Beatson reported that removal of the ovaries from premenopausal women with advanced breast cancer produced a dramatic decrease in tumor size 4, and the development of contraceptive drugs further inspired research on the estrogen system 5.
The relation between estrogens and breast cancer is built on the observation that an increased exposure to E2 in women during lifetime (early menarche, delayed menopause, null parity) was linked to an increased risk of developing breast cancer and ovariectomy was used to treat severe forms of the tumor 4.
About 2/3(rd) cases of breast cancer are related to hormone mediated malignancy itself. A hormone receptor positive breast cancer represents cells displaying rigorous proliferation upon hormonal exposure. BRCA1 is the predominant marker gene responsible for estrogen regulation 6. Observations on the role of ovarian hormones in breast cancer growth, as well as interest in contraception, stimulated research into the biology of estrogens. The identification of the classical receptors ERα and ERβ and the transmembrane receptor GPER and the resolution of the structure of the ligand bound to its receptor established the principal molecular mechanisms of estrogen action. The presence of estrogen-like compounds in many plants used in traditional medicine or ingested as food ingredients, phytoestrogens, as well as the estrogenic activities of many industrial pollutants and pesticides, xenoestrogens, have prompted investigations into their role in human health. Phyto- and xenoestrogens bind to the estrogen receptors with a lower affinity than the endogenous estrogens and can compete or substitute the hormone. Xenoestrogens, which accumulate in the body throughout life, are believed to increase breast cancer risk, especially in cases of prenatal and prepuberal exposure whereas the role of phytoestrogens is still a matter of debate. At present, the application of phytoestrogens appears to be limited to the treatment of post-menopausal symptoms in women where the production of endogenous estrogens has ceased 7.
The pattern of breast cancer in the Kingdom of Saudi Arabia is very disturbing. It usually presents at advanced stages and more frequently in young pre-menopausal women in comparison to western countries 8, 9. The deprived knowledge and incorrect beliefs about breast cancer prevention among women are responsible for a negative perception of the curability of a cancer detected early and of the usefulness of the avoiding risk factors.
This study aimed to determine breast cancer related awareness and approach toward exposure to diverse patterns of hormones among women in Northern Saudi Arabia.
In this descriptive cross sectional study, essential identification data about breast cancer risk factors were obtained from 400 Saudi females living in the city of Hail, Saudi Arabia. Participants were randomly selected by simple random method regardless to age, gender and education.
Purposeful questionnaire was designed and used for obtaining of the necessary data. The following information were obtained from each participant: age, sex, breast cancer may be inherited, hormonal exposure (Estrogen (RE)) increase the risk of breast cancer, early puberty and late menopause increase the risk of breast cancer, delayed and repeating child birth increase the risk of breast cancer, natural breast feeding decreases the risk of breast cancer.
2.1. Data AnalysisStatistical Package for Social Sciences (version 16) was used for analysis and to perform Pearson Chi-square test for statistical significance (P value). The 95% confidence level and confidence intervals were used. P value less than 0.05 was considered statistically significant.
2.2. Ethical ConsentEach participant was asked to sign a written ethical consent during the questionnaire’s interview. The informed ethical consent form was designed and approved by the ethical committee of the College of Medicine (University of Hail, Saudi Arabia) Research Board.
This cross-sectional survey included 400 females living in the city of Hail, Northern Saudi Arabia, their ages ranging from 14 to 52 with a mean age of 28 years. The great majority of the study subjects were found at age group 21-24 years followed by 35+, < 20 years, 25-29 and 30-34 years representing 145, 95, 64, 49, and 47 respectively as shown in Figure 1.
With regard to the relationship of the study population by age and level of education, the great majority of the study subjects were found at university level representing 262/400(65.5%) followed by basic and secondary levels constituting 101/400(25.3%) and 37/400(9.2%), in this order. Most of the individuals with basic level of education were found among age range 35+ years followed by 30-34, and 25-29 years, representing 44/101(43.6%), 25/101(24.8%) and 20/101 (19.8%), respectively. Most of the individuals with secondary level of education were found among age range <20 years followed by 35+ and 25-29 years, representing 24/37(64.7%), 7/37(18.9%) and 5/37(13.5%), respectively. Most of the individuals with university level of education were found among age range 21-24 years followed by 35+ years and <20 years, representing 139/262(53.1%), 44/262(16.8%) and 34/262(13%), respectively, as indicated in Table 1, Figure 2.
When the participants were asked “Rate your current knowledge about breast cancer" Out of the 400 respondents, 154/400(38.5%), 125/400(31.3%), 64/400(16%) and 54/400(13.5%) have stated average, poor, good and know nothing, correspondingly. With regard to the age, out of the 154 individuals with average level, 65/154(42.2%), 26/154(16.9%), 25/154(16.2%) were found at age ranges, 21-24 years, <20 years, and 35+ years, respectively. For those indicated poor, the majority were found at age group 21-24 years followed by 35+ and <20 years, constituting 37/125(29.6%), 36/125(28.8%) and 23/125(18.4%), respectively. For those indicated good the majority were found at age group 21-24 years followed by 35+ years, constituting 30/64(46.9%), 16/64(25%), respectively, as indicated in Table 1.
When the participants were asked “Do you care to know about breast cancer?" Out of the 393 respondents, 43/393(10.9%) have stated yes, and the remaining 350/393(89.1%) have stated no. Out of the 43 positively stated, the majority of them were found at age group 21-24 years followed by < 20 years, constituting 19/43(35.8%) and 8/43(18.6%), respectively, as indicated in Table 1.
When the participants were asked “Is the breast cancer the commonest females' cancer in Saudi?" Out of the 396 respondents, 343/396(86.6%) have stated yes, 31/396 (7.8%) have stated no and 22/396 (5.6%) stated don't know. Out of the 343 positively stated, the majority of them were found at age group 21-24 years followed by 35+ years, constituting 128/343(37.3%) and 81/343 (23.6%), respectively, as indicated in Table 1.
Table 2, summarizes the distribution of the study subjects by age and level of knowledge about the relationship between breast cancer and hormonal exposure. On asking the participants the question “Does the over exposure to hormones (ER) increases the risk of breast cancer” Out of 387 respondents, 184, 84 and 117 answered Yes increases the risk of breast cancer, No and decreases the risk of breast cancer, respectively. The majority of those stated Yes were found among age group 21-24 years followed by 35+ years representing 90/184 (48.9%) and 34/184(18.5%), respectively.
On asking the participants the question “Does early puberty and late menopause increase the risk of breast cancer” Out of 395 respondents, 139, 205 and 51 answered yes increases the risk of breast cancer, No and decreases the risk of breast cancer, respectively. The majority of those stated Yes were found among age group 21-24 years followed by 35+ years representing 72/139 (51.8%) and 25/139(18%), respectively.
On asking the participants the question “Does delayed child birth increases the risk of breast cancer” Out of 396 respondents, 171, 195 and 30 answered yes increases the risk of breast cancer, No and Decreases the risk of breast cancer, respectively. The majority of those stated Yes were found among age group 21-24 years followed by 35+ years representing 76/171(44.4%) and 37/171(21.6%), respectively.
On asking the participants the question “Does delayed natural breast feeding decreases the risk of breast cancer” Out of 397 respondents, 335, 39 and 23 answered Yes increases the risk of breast cancer, No and Decreases the risk of breast cancer, respectively. The majority of those stated Yes were found among age group 21-24 years followed by 35+ years representing 121/335(36%) and 85/335(25.4%), respectively.
Table 3 summarizes the distribution of the study subjects by education and level of knowledge about the relationship between breast cancer and hormonal exposure. When asking the respondents the question “Does the over exposure to hormones (ER) increases the risk of breast cancer” Out of the 184 stated “Yes”, 135, 42 and 7 were at university level, basic and secondary level, respectively, as shown in Figure 3. When asking the respondents the question “Does early puberty and late menopause increase the risk of breast cancer” Out of the 139 stated “Yes”, 103, 24 and 12 were at university level, basic and secondary level, respectively, as shown in Figure 4. When asking the respondents the question “Does delayed child birth increases the risk of breast cancer” Out of the 171 stated “Yes”, 127, 36 and 8 were at university level, basic and secondary level, respectively, as shown in Fig 5. When asking the respondents the question “Does delayed natural breast feeding decreases the risk of breast cancer” Out of the 335 stated “Yes”, 220, 89 and 26 were at university level, basic and secondary level, respectively, as shown Figure 6.
In the present study, we evaluated breast cancer related awareness and approach toward exposure to diverse patterns of hormones among women in Northern Saudi Arabia. Breast cancer is influenced by multiple risk factors, which include the risk factors such as those linked to the hazardous effects of hormonal exposures such as early age at menarche, late age at menopause 10, fewer number of children and null parity, late age at first birth 11, little or no breastfeeding and long-term use of hormone replacement therapy (HRT) 12, 13, 14, 15.
In the present study, on asking the participants the question “Does the over exposure to hormones (ER) increases the risk of breast cancer” Out of 387 respondents, 184 /387(47.5%) answered Yes increases the risk of breast cancer. Although, this percentage was lower than what was expected but it seemed relatively reasonable in a population. Estrogen hormones have an extensive impact on both normal development and tumorigenesis of the breast 16. The IARC first established that there was adequate evidence that estrogen-only menopausal hormone therapy (MHT) was carcinogenic to human since 1999 17. In a subsequent report published in 2012, IARC also reported that there was sufficient evidence that estrogen plus a progestogen (combined MHT) was carcinogenic 18. In a study reanalyzed around 90% of the global epidemiological evidence on the relationship between breast cancer risk and hormone replacement therapy (HRT) usage, breast cancer risk was found to increase in women using HRT and increases with increasing duration of use 19. There is a paucity of data regarding HRT from KSA, the only one study undertaken this topic in 2003 and reported a prevalence rate of HRT of 5% 20. A recent study from KSA have reported long term use of oral contraceptive pills (OCP) in KSA and its association within creased breast cancer risk 21.
On asking the participants the question “Does early puberty and late menopause increase the risk of breast cancer” Out of 395 respondents, 139 answered yes increases the risk of breast cancer. Menarche and menopause denote the start and end, correspondingly, of reproduction age, and both affect breast cancer risk 22. Although, the mechanisms underlying this association are not well understood, but may be due to elevated levels of estrogen both earlier 23 and later 24 in life in girls with earlier menarche.
On asking the participants the question “Does delayed child birth increases the risk of breast cancer” Out of 396 respondents, 171 answered yes increases the risk of breast cancer. It was strongly proven that women having their first birth before the age of 18 years old have only about one-third the breast cancer risk of those whose first birth after the age of 35 years. The influence of age at first birth in reducing breast cancer risk involves testing of varieties of etiological hypotheses 25.
On asking the participants the question “Does delayed natural breast feeding decreases the risk of breast cancer” Out of 397 respondents, 335 answered yes increases the risk of breast cancer. Results of a meta-analysis showed a protective effect of ever breastfeeding against breast cancers with hormone receptor-negative, which are more frequent in younger females and commonly have a poorer prognosis than other sub-types of breast cancer 26.The World Health Organization (WHO) has endorsed limited breastfeeding for 6 months after birth 27. The existing practice of Saudi infants’ feeding is extremely far from compliance with even the most conservative WHO endorsements of limited breastfeeding for 4–6 months. A study from Saudi Arabia showed that bottle feeding was introduced by 1 month of age to 51.4% of children and to 90% by 6 months of age 28. These findings at least show that high pro-portions of Saudi mothers practice breastfeeding for short period of time, which may increase the risk of breast cancer.
In general knowledge of hormonal breast cancer risk factors is not so strong so as to achieve the intended values in Northern Saudi Arabia. Knowledge of breast cancer risk factors can powerfully participate to the breast cancer prevention struggles, which will have the chief results mainly if started at an early age and continued over a lifetime. Gaps in knowledge are rendered anticipated and deserve respected responsiveness to clarify prevention.
The authors would like to express their special appreciation and thanks to every one offered his efforts and time to participate in this study, in particular the volunteers.
[1] | Vich P, Brusint B, Alvarez-Hernández C, Cuadrado-Rouco C, Diaz-García N, Redondo-Margüello E. Update of breast cancer in primary care (I/V). Semergen 2014; 40(6): 326-33. | ||
In article | View Article PubMed | ||
[2] | Ghoncheh M, Mohammadian-Hafshejani A, Salehiniya H. Incidence and Mortality of Breast Cancer and their Relationship to Development in Asia. Asian Pac J Cancer Prev 2015; 16(14): 6081-7. | ||
In article | View Article PubMed | ||
[3] | Corbex M, Bouzbid S, Boffetta P. Features of breast cancer in developing countries, examples from North-Africa. Eur J Cancer 2014; 50(10): 1808-18. | ||
In article | View Article PubMed | ||
[4] | Beatson G. On the treatment of inoperable cases of carcinoma of the mamma suggestions for a new method of treatment with illustrative cases. Lancet 1896; 148:162-165. | ||
In article | View Article | ||
[5] | Jensen EV, Jacobsonk HI. Basic guides to the mechanism of estrogen action. Recent Prog. Horm. Res 1962; 18:387-414. | ||
In article | View Article | ||
[6] | Zghair AN, Sharma R, Sharma AK. Hormone responsive breast cancer and BRCA1 mutation: mechanism, regulation and iron-mediated effects. Curr Pharm Biotechnol 2014; 15(12):1113-24. | ||
In article | View Article PubMed | ||
[7] | Albini A, Rosano C, Angelini G, et al. Exogenous Hormonal Regulation in Breast Cancer Cells by Phytoestrogens and Endocrine Disruptors. Current Medicinal Chemistry 2014; 21: 1129-1145. | ||
In article | View Article PubMed | ||
[8] | Mansoor I. Profile of female breast lesions in Saudi Arabia. J Pak Med Assoc 2001; 51(7): 243-7. | ||
In article | PubMed | ||
[9] | Chiedozi LC, El-Hag IA, Kollur SM. Breast diseases in the Northern region of Saudi Arabia. Saudi Med J 2003; 24(6): 623-7. | ||
In article | PubMed | ||
[10] | ESHRE Capri Workshop Group. Hormones and breast cancer. Hum Reprod Update 2004; 10(4): 281-93. | ||
In article | View Article PubMed | ||
[11] | Albrektsen G, Heuch I, Hansen S, Kvåle G. Breast cancer risk by age at birth, time since birth and time intervals between births: Exploring interaction effects. Br J Cancer 2005; 92: 167-75. | ||
In article | View Article PubMed | ||
[12] | Lipworth L, Bailey LR, Trichopoulos D. History of breast feeding in relation to breast cancer risk: A review of the epidemiologic literature. J Natl Cancer Inst 2000; 92: 302-12. | ||
In article | View Article PubMed | ||
[13] | Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breast feeding: Collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without disease. Lancet 2002; 360: 187-95. | ||
In article | View Article | ||
[14] | Beral V. Million women study collaborators. Breast cancer and hormone replacement therapy in the million women study. Lancet 2003; 362: 419-27. | ||
In article | View Article | ||
[15] | Hulley S, Furberg C, Barrett-Connor E, Cauley J, Grady D, Haskell W, et al. Non-cardiovascular disease outcomes during 6-8 years with hormone therapy. Heart and Estrogen/Progesterone Replacement Study Follow-Up (HERSII) JAMA 2002; 288: 58-66. | ||
In article | View Article PubMed | ||
[16] | M. Fahlén H, Zhang L, Löfgren B, Masironi VONE, Schoultz VONBO, Schoultz L. Sahlin, Expression of estrogen receptors in relation to hormone levels and the Nottingham Prognostic Index, Anticancer Res 2016; 36 (6): 2839-2847. | ||
In article | PubMed | ||
[17] | IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Hormonal Contraception and Post-Menopausal Hormonal Therapy, vol. 72, World Health Organization, Lyon (FRC), 1999. | ||
In article | |||
[18] | IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, Pharmaceuticals A Review of Human Carcinogens, vol. 100 A, World Health Organization, Lyon (FRC), 2012. | ||
In article | View Article | ||
[19] | Collaborative Group on Hormonal Factors in Breast Cancer, Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51epidemiological studies of 52,705 women with breast cancer and 108,411women without breast cancer, Lancet 1997; 350 (9084): 1047-1059. | ||
In article | View Article | ||
[20] | Bakarman MA, Abu Ahmed HA. Awareness of hormonal replacement therapy among females attending primary health care centers in Western Saudi Arabia, Saudi Med J 2003; 24 (5): 488-492. | ||
In article | PubMed | ||
[21] | Karim SM, Baeshen W, Neamatullah SN, Bin B. Oral contraceptives, abortion and breast cancer risk: a case control study in Saudi Arabia, Asian Pac. J. Cancer Prev. 2015; 16 (9): 3957-3960. | ||
In article | View Article PubMed | ||
[22] | Collaborative Group on Hormonal Factors in Breast Cancer, Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. Lancet Oncol 2012;13 (11): 1141-1151. | ||
In article | View Article | ||
[23] | Shi L, Remer T, Buyken AE, et al. Prepubertal urinary estrogen excretion and its relationship with pubertal timing, Am. J. Physiol. Endocrinol. Metab. 2010; 299 (6): E990-E997. | ||
In article | View Article PubMed | ||
[24] | Madigan MP, Troisi R, Potischman N, Dorgan JF, Brinton LA, Hoover RN. Serum hormone levels in relation to reproductive and lifestyle factors in postmenopausal women (United States), Cancer Causes Control1998; 9 (2): 199-207. | ||
In article | View Article PubMed | ||
[25] | MacMahon B, Cole P, Lin TM, et al. Age at first birth and breast cancer risk, Bull. World Health Organ 1970; 43 (2): 209-221. | ||
In article | PubMed PubMed | ||
[26] | Islami F, Liu Y, Jemal A, et al. Breastfeeding and breast cancer risk by receptor status – asystematic review and meta-analysis, Ann. Oncol. 2015; 26 (12): 2398-2407. | ||
In article | PubMed PubMed | ||
[27] | Kramer MS, Kakuma R. Optimal duration of exclusive breastfeeding, Cochrane Database Syst. Rev. 2012; (8): CD003517. | ||
In article | View Article | ||
[28] | El Mouzan MI, Al Omar AA, Al Salloum AA, Al Herbish AS, Qurachi MM. Trends in infant nutrition in Saudi Arabia: compliance with WHO recommendations, Ann. Saudi Med. 29 (1) (2009). 20-23. | ||
In article | View Article PubMed | ||
Published with license by Science and Education Publishing, Copyright © 2017 Ibrahim A. Bin ahmed, Saleh Hadi Alharbi, Fayez Saud Alreshidi, Sami Awejan Alrashedi, Ali Ghannam Alrashidi, Kalaf Jaze Kalaf Alshammeri and Hussain Gadelkarim Ahmed
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/
[1] | Vich P, Brusint B, Alvarez-Hernández C, Cuadrado-Rouco C, Diaz-García N, Redondo-Margüello E. Update of breast cancer in primary care (I/V). Semergen 2014; 40(6): 326-33. | ||
In article | View Article PubMed | ||
[2] | Ghoncheh M, Mohammadian-Hafshejani A, Salehiniya H. Incidence and Mortality of Breast Cancer and their Relationship to Development in Asia. Asian Pac J Cancer Prev 2015; 16(14): 6081-7. | ||
In article | View Article PubMed | ||
[3] | Corbex M, Bouzbid S, Boffetta P. Features of breast cancer in developing countries, examples from North-Africa. Eur J Cancer 2014; 50(10): 1808-18. | ||
In article | View Article PubMed | ||
[4] | Beatson G. On the treatment of inoperable cases of carcinoma of the mamma suggestions for a new method of treatment with illustrative cases. Lancet 1896; 148:162-165. | ||
In article | View Article | ||
[5] | Jensen EV, Jacobsonk HI. Basic guides to the mechanism of estrogen action. Recent Prog. Horm. Res 1962; 18:387-414. | ||
In article | View Article | ||
[6] | Zghair AN, Sharma R, Sharma AK. Hormone responsive breast cancer and BRCA1 mutation: mechanism, regulation and iron-mediated effects. Curr Pharm Biotechnol 2014; 15(12):1113-24. | ||
In article | View Article PubMed | ||
[7] | Albini A, Rosano C, Angelini G, et al. Exogenous Hormonal Regulation in Breast Cancer Cells by Phytoestrogens and Endocrine Disruptors. Current Medicinal Chemistry 2014; 21: 1129-1145. | ||
In article | View Article PubMed | ||
[8] | Mansoor I. Profile of female breast lesions in Saudi Arabia. J Pak Med Assoc 2001; 51(7): 243-7. | ||
In article | PubMed | ||
[9] | Chiedozi LC, El-Hag IA, Kollur SM. Breast diseases in the Northern region of Saudi Arabia. Saudi Med J 2003; 24(6): 623-7. | ||
In article | PubMed | ||
[10] | ESHRE Capri Workshop Group. Hormones and breast cancer. Hum Reprod Update 2004; 10(4): 281-93. | ||
In article | View Article PubMed | ||
[11] | Albrektsen G, Heuch I, Hansen S, Kvåle G. Breast cancer risk by age at birth, time since birth and time intervals between births: Exploring interaction effects. Br J Cancer 2005; 92: 167-75. | ||
In article | View Article PubMed | ||
[12] | Lipworth L, Bailey LR, Trichopoulos D. History of breast feeding in relation to breast cancer risk: A review of the epidemiologic literature. J Natl Cancer Inst 2000; 92: 302-12. | ||
In article | View Article PubMed | ||
[13] | Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breast feeding: Collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without disease. Lancet 2002; 360: 187-95. | ||
In article | View Article | ||
[14] | Beral V. Million women study collaborators. Breast cancer and hormone replacement therapy in the million women study. Lancet 2003; 362: 419-27. | ||
In article | View Article | ||
[15] | Hulley S, Furberg C, Barrett-Connor E, Cauley J, Grady D, Haskell W, et al. Non-cardiovascular disease outcomes during 6-8 years with hormone therapy. Heart and Estrogen/Progesterone Replacement Study Follow-Up (HERSII) JAMA 2002; 288: 58-66. | ||
In article | View Article PubMed | ||
[16] | M. Fahlén H, Zhang L, Löfgren B, Masironi VONE, Schoultz VONBO, Schoultz L. Sahlin, Expression of estrogen receptors in relation to hormone levels and the Nottingham Prognostic Index, Anticancer Res 2016; 36 (6): 2839-2847. | ||
In article | PubMed | ||
[17] | IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Hormonal Contraception and Post-Menopausal Hormonal Therapy, vol. 72, World Health Organization, Lyon (FRC), 1999. | ||
In article | |||
[18] | IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, Pharmaceuticals A Review of Human Carcinogens, vol. 100 A, World Health Organization, Lyon (FRC), 2012. | ||
In article | View Article | ||
[19] | Collaborative Group on Hormonal Factors in Breast Cancer, Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51epidemiological studies of 52,705 women with breast cancer and 108,411women without breast cancer, Lancet 1997; 350 (9084): 1047-1059. | ||
In article | View Article | ||
[20] | Bakarman MA, Abu Ahmed HA. Awareness of hormonal replacement therapy among females attending primary health care centers in Western Saudi Arabia, Saudi Med J 2003; 24 (5): 488-492. | ||
In article | PubMed | ||
[21] | Karim SM, Baeshen W, Neamatullah SN, Bin B. Oral contraceptives, abortion and breast cancer risk: a case control study in Saudi Arabia, Asian Pac. J. Cancer Prev. 2015; 16 (9): 3957-3960. | ||
In article | View Article PubMed | ||
[22] | Collaborative Group on Hormonal Factors in Breast Cancer, Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. Lancet Oncol 2012;13 (11): 1141-1151. | ||
In article | View Article | ||
[23] | Shi L, Remer T, Buyken AE, et al. Prepubertal urinary estrogen excretion and its relationship with pubertal timing, Am. J. Physiol. Endocrinol. Metab. 2010; 299 (6): E990-E997. | ||
In article | View Article PubMed | ||
[24] | Madigan MP, Troisi R, Potischman N, Dorgan JF, Brinton LA, Hoover RN. Serum hormone levels in relation to reproductive and lifestyle factors in postmenopausal women (United States), Cancer Causes Control1998; 9 (2): 199-207. | ||
In article | View Article PubMed | ||
[25] | MacMahon B, Cole P, Lin TM, et al. Age at first birth and breast cancer risk, Bull. World Health Organ 1970; 43 (2): 209-221. | ||
In article | PubMed PubMed | ||
[26] | Islami F, Liu Y, Jemal A, et al. Breastfeeding and breast cancer risk by receptor status – asystematic review and meta-analysis, Ann. Oncol. 2015; 26 (12): 2398-2407. | ||
In article | PubMed PubMed | ||
[27] | Kramer MS, Kakuma R. Optimal duration of exclusive breastfeeding, Cochrane Database Syst. Rev. 2012; (8): CD003517. | ||
In article | View Article | ||
[28] | El Mouzan MI, Al Omar AA, Al Salloum AA, Al Herbish AS, Qurachi MM. Trends in infant nutrition in Saudi Arabia: compliance with WHO recommendations, Ann. Saudi Med. 29 (1) (2009). 20-23. | ||
In article | View Article PubMed | ||